Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Beijing Biotech
Daiichi Sankyo
Imunon
Blue Earth Diagnostics
AbbVie
Myeloid Therapeutics
Leiden University Medical Center
Incyte Corporation
Fundacion Clinic per a la Recerca Biomédica
Case Comprehensive Cancer Center
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
AstraZeneca
TORL Biotherapeutics, LLC
Shanghai Gynecologic Oncology Group
Avenzo Therapeutics, Inc.
Institut Claudius Regaud
Radboud University Medical Center
Oncology Institute of Southern Switzerland
AGO Research GmbH
Massachusetts General Hospital
UNC Lineberger Comprehensive Cancer Center
National Cancer Center, Korea
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Bicara Therapeutics
Massachusetts General Hospital
858 Therapeutics, Inc.
Context Therapeutics Inc.
Medicenna Therapeutics, Inc.
Imperial College Healthcare NHS Trust
Memorial Sloan Kettering Cancer Center
Stanford University
Università degli Studi dell'Insubria
Bio-Path Holdings, Inc.
Northwestern University
Institut du Cancer de Montpellier - Val d'Aurelle
Ente Ospedaliero Ospedali Galliera
European Institute of Oncology
Region Västerbotten
University of Pittsburgh
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Light Chain Bioscience - Novimmune SA
Anhui Provincial Hospital
Hospices Civils de Lyon
Cukurova University
Shantou University Medical College
Second Affiliated Hospital of Wenzhou Medical University